Shares have been under pressure on drug pricing headlines but should benefit from stronger revenue and expectations of 5.9 % earnings growth this year. (dailytradealert.com)
The debate over high drug prices has been a red hot topic here and inspired a lot of anger and legislative threats, especially in the midst of the 2016 election cycle. (fortune.com)
The poster boy for prescription drug price increases was arrested on securities fraud charges this week. (entrepreneur.com)